StockData
enGene Therapeutics Inc. logo

enGene Therapeutics Inc. (ENGN) stock

ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 3/30
$1.72−0.17 (-8.99%)

Close on Nov 17, 2026Market cap $115.27MP/E –Yield 0.00%

enGene Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

enGene Therapeutics's market cap was $120.63M on Nov 11, 2026, against $412.42M a year earlier. Over the last 4 years it ranged from $5.10M to $525.91M, with a median of $211.05M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$120.63M-74.3%
2025Dec 31, 2025$469.73M+38.6%
2024Dec 31, 2024$338.99M+58.3%
2023Dec 29, 2023$214.12M+3013.4%
2022Dec 30, 2022$6.88M–

More enGene Therapeutics figures

See a number that looks wrong?